Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Biological Psychiatry|December 24, 2005
High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNOMatthäus Willeit, Nathalie Ginovart, Shitij Kapur, et al.
Journal of Affective Disorders|July 12, 2014
Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind studySidney H Kennedy, Peter Giacobbe, Franca Placenza, et al.
Journal of Biomolecular Structure & Dynamics|July 2, 2016
The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligandsRamin Ekhteiari Salmas, Matthias Stein, Mine Yurtsever, et al.
ACS Medicinal Chemistry Letters|June 14, 2011
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 ReceptorsAnna W Sromek, Yu-Gui Si, Tangzhi Zhang, et al.
Nuclear Medicine and Biology|February 20, 2007
Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNONeil Vasdev, Philip Seeman, Armando Garcia, et al.
ACS Chemical Neuroscience|March 9, 2017
Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus DockingRamin Ekhteiari Salmas, Philip Seeman, Busecan Aksoydan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 12, 2013
The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaquesJames B Koprich, Philippe Huot, Susan H Fox, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 5, 2007
First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography studyMatthäus Willeit, Nathalie Ginovart, Ariel Graff, et al.
Journal of Medicinal Chemistry|June 10, 2005
Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomographyAlan A Wilson, Patrick McCormick, Shitij Kapur, et al.
Synapse (New York, N.Y.)|June 21, 2006
Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomographyNeil Vasdev, Sridhar Natesan, Laurent Galineau, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Biological Psychiatry|December 24, 2005
High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNOMatthäus Willeit, Nathalie Ginovart, Shitij Kapur, et al.
Journal of Affective Disorders|July 12, 2014
Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind studySidney H Kennedy, Peter Giacobbe, Franca Placenza, et al.
Journal of Biomolecular Structure & Dynamics|July 2, 2016
The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligandsRamin Ekhteiari Salmas, Matthias Stein, Mine Yurtsever, et al.
ACS Medicinal Chemistry Letters|June 14, 2011
Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 ReceptorsAnna W Sromek, Yu-Gui Si, Tangzhi Zhang, et al.
Nuclear Medicine and Biology|February 20, 2007
Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNONeil Vasdev, Philip Seeman, Armando Garcia, et al.
ACS Chemical Neuroscience|March 9, 2017
Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus DockingRamin Ekhteiari Salmas, Philip Seeman, Busecan Aksoydan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 12, 2013
The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaquesJames B Koprich, Philippe Huot, Susan H Fox, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 5, 2007
First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography studyMatthäus Willeit, Nathalie Ginovart, Ariel Graff, et al.
Journal of Medicinal Chemistry|June 10, 2005
Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomographyAlan A Wilson, Patrick McCormick, Shitij Kapur, et al.
Synapse (New York, N.Y.)|June 21, 2006
Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomographyNeil Vasdev, Sridhar Natesan, Laurent Galineau, et al.
Pageof 9